Prognostic Significance of Periprocedural Versus Spontaneously Occurring Myocardial Infarction After Percutaneous Coronary Intervention in Patients With Acute Coronary Syndromes. An Analysis From the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) Trial

Journal of the American College of Cardiology

Volumn 54, Issue 5, 2009, Pages 477-486

  Prasad, Abhiram ^a   Gersh, Bernard J ^a   Bertrand, Michel E ^b   Lincoff, A Michael ^c   Moses, Jeffrey W ^d   Ohman, E Magnus ^e   White, Harvey D ^f   Pocock, Stuart J ^g   McLaurin, Brent T ^h   Cox, David A ⁱ   Lansky, Alexandra J ^d   Mehran, Roxana ^d   Stone, Gregg W ^d  

^a MAYO CLINIC   (United States)

^b LILLE UNIVERSITY HOSPITAL   (France)

^c LERNER RESEARCH INSTITUTE   (United States)

^d NewYork Presbyterian Hospital   (United States)

^e DUKE UNIVERSITY MEDICAL CENTER   (United States)

^f AUCKLAND CITY HOSPITAL   (New Zealand)

^g LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^h Anderson Heart   (United States)

ⁱ Mid Carolina Cardiology   (United States)

Author keywords

angioplasty; myocardial infarction; prognosis

Indexed keywords

ACUTE CORONARY SYNDROME; ADULT; ARTICLE; ATHEROSCLEROSIS; CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; SURVIVAL; TREATMENT OUTCOME;

EID: 67650665776     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2009.03.063     Document Type: Article

References (30)

1. Herrmann J. Peri-procedural myocardial injury: 2005 update. Eur Heart J 26 (2005) 2493-2519
2. Ellis S.G., Chew D., Chan A., Whitlow P.L., Schneider J.P., and Topol E.J. Death following creatine kinase-MB elevation after coronary intervention: identification of an early risk period: importance of creatine kinase-MB level, completeness of revascularization, ventricular function, and probable benefit of statin therapy. Circulation 106 (2002) 1205-1210
3. Kini A., Marmur J.D., Kini S., et al. Creatine kinase-MB elevation after coronary intervention correlates with diffuse atherosclerosis, and low-to-medium level elevation has a benign clinical course: implications for early discharge after coronary intervention. J Am Coll Cardiol 34 (1999) 663-671
4. Stone G.W., Mehran R., Dangas G., Lansky A.J., Kornowski R., and Leon M.B. Differential impact on survival of electrocardiographic Q-wave versus enzymatic myocardial infarction after percutaneous intervention: a device-specific analysis of 7147 patients. Circulation 104 (2001) 642-647
5. Saucedo J.F., Mehran R., Dangas G., et al. Long-term clinical events following creatine kinase-myocardial band isoenzyme elevation after successful coronary stenting. J Am Coll Cardiol 35 (2000) 1134-1141
6. Kong T.Q., Davidson C.J., Meyers S.N., Tauke J.T., Parker M.A., and Bonow R.O. Prognostic implication of creatine kinase elevation following elective coronary artery interventions. JAMA 277 (1997) 461-466
7. Abdelmeguid A.E., Topol E.J., Whitlow P.L., Sapp S.K., and Ellis S.G. Significance of mild transient release of creatine kinase-MB fraction after percutaneous coronary interventions. Circulation 94 (1996) 1528-1536
8. Bhatt D.L., and Topol E.J. Does creatinine kinase-MB elevation after percutaneous coronary intervention predict outcomes in 2005?. Periprocedural cardiac enzyme elevation predicts adverse outcomes. Circulation 112 (2005) 906-915
9. Cutlip D.E., and Kuntz R.E. Does creatinine kinase-MB elevation after percutaneous coronary intervention predict outcomes in 2005?. Cardiac enzyme elevation after successful percutaneous coronary intervention is not an independent predictor of adverse outcomes. Circulation 112 (2005) 916-922
10. Erbel R., and Heusch G. Coronary microembolization. J Am Coll Cardiol 36 (2000) 22-24
11. Bahrmann P., Werner G.S., Heusch G., et al. Detection of coronary microembolization by Doppler ultrasound in patients with stable angina pectoris undergoing elective percutaneous coronary interventions. Circulation 115 (2007) 600-608
12. Fuster V., Badimon L., Badimon J., and Chesebro J.H. The pathogenesis of coronary artery disease and the acute coronary syndromes (1). N Engl J Med 326 (1992) 242-250
13. Fuster V., Badimon L., Badimon J., and Chesebro J.H. The pathogenesis of coronary artery disease and the acute coronary syndromes (2). N Engl J Med 326 (1992) 310-318
14. de Winter R.J., Windhausen F., Cornel J.H., et al., Invasive versus Conservative Treatment in Unstable Coronary Syndromes (ICTUS) Investigators. Early invasive versus selectively invasive management for acute coronary syndromes. N Engl J Med 353 (2005) 1095-1104
15. Boden W.E., O'Rourke R.A., Teo K.K., et al. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med 35 (2007) 1503-1516
16. Hirsch A., Windhausen F., Tijssen J.G., Verheugt F.W., Cornel J.H., de Winter R.J., and Invasive versus Conservative Treatment in Unstable coronary Syndromes (ICTUS) Investigators. Long-term outcome after an early invasive versus selective invasive treatment strategy in patients with non-ST-elevation acute coronary syndrome and elevated cardiac troponin T (the ICTUS trial): a follow-up study. Lancet 369 (2007) 827-835
17. Stone G.W., Bertrand M., Colombo A., et al. Acute Catheterization and Urgent Intervention Triage strategY (ACUITY) trial: study design and rationale. Am Heart J 148 (2004) 764-775
18. Stone G.W., Ware J.H., Bertrand M.E., et al. Antithrombotic strategies in patients with acute coronary syndromes undergoing early invasive management: one-year results from the ACUITY trial. JAMA 98 (2007) 2497-2506
19. Stone G.W., White H.D., Ohman E.M., et al. Bivalirudin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a subgroup analysis from the Acute Catheterization and Urgent Intervention Triage strategy (ACUITY) trial. Lancet 369 (2007) 907-919
20. Antman E.M., Cohen M., Bernink P.J., et al. The TIMI risk score for unstable angina/non-ST elevation MI: a method for prognostication and therapeutic decision making. JAMA 284 (2000) 835-842
21. Anderson J.L., Adams C.D., Antman E.M., et al. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction). J Am Coll Cardiol 50 (2007) e1-e157
22. Prasad A., Rihal C.S., Singh M., Lennon R., Jaffe A., and Holmes D. Significance of periprocedural myonecrosis for outcomes following percutaneous coronary intervention. An analysis of pre and post intervention troponin T levels in 5487 patients. Circ Cardiovasc Intervent 1 (2008) 10-19
23. Mehran R., Dangas G., Mintz G.S., et al. Atherosclerotic plaque burden and CK-MB enzyme elevation after coronary interventions: intravascular ultrasound study of 2256 patients. Circulation 101 (2000) 604-610
24. Ricciardi M.J., Wu E., Davidson C.J., et al. Visualization of discrete microinfarction after percutaneous coronary intervention associated with mild creatine kinase-MB elevation. Circulation 103 (2001) 2780-2783
25. Porto I., Selvanayagam J.B., Van Gaal W.J., et al. Plaque volume and occurrence and location of periprocedural myocardial necrosis after percutaneous coronary intervention: insights from delayed-enhancement magnetic resonance imaging, thrombolysis in myocardial infarction myocardial perfusion grade analysis, and intravascular ultrasound. Circulation 114 (2006) 662-669
26. Kernis S.J., Harjai K.J., Stone G., et al. The incidence, predictors, and outcomes of early reinfarction after primary angioplasty for acute myocardial infarction. J Am Coll Cardiol 42 (2003) 1173-1177
27. De Luca G., Ernst N., van't Hof A.W., et al. Predictors and clinical implications of early reinfarction after primary angioplasty for ST-segment elevation myocardial infarction. Am Heart J 151 (2006) 1256-1259
28. Akkerhuis K.M., Alexander J.H., Tardiff B.E., et al. Minor myocardial damage and prognosis: are spontaneous and percutaneous coronary intervention-related events different?. Circulation 105 (2002) 554-556
29. Thygesen K., Alpert J.S., White H.D., and Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction. Universal definition of myocardial infarction. J Am Coll Cardiol 50 (2007) 2173-2195
30. Loscalzo J. Clinical trials in cardiovascular medicine in an era of marginal benefit, bias, and hyperbole. Circulation 112 (2005) 3026-3029